Healyx Changes Lives by Treating Chronic Wounds

Lower-cost, more-effective treatments are the hallmark of many Fogarty Institute companies, and that is the principle Healyx is living up to with its device that provides gold standard care for a chronic problem at a significant cost reduction.

Non-healing wounds are a critical global issue, with over eight million Medicare patients afflicted at an annual cost of $31.7 billion in the U.S.

Stanford Neurosurgeon and Entrepreneur Inspires Audience at 20th Annual Fogarty Lecture

This year’s annual Thomas J. Fogarty Lecture marked a milestone with the celebration of its 20thanniversary. The series, hosted by Stanford Biodesign and co-sponsored by the Fogarty Institute, started as a gathering to discuss and promote medical innovation with approximately 30 people in attendance. Since then, it has grown into a preeminent opportunity to learn from the most notable innovators in health technology.

START TYPING AND PRESS ENTER TO SEARCH